Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 32 of 2528 for:    "Plasma Cell Neoplasm"

Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00305812
Recruitment Status : Completed
First Posted : March 22, 2006
Last Update Posted : November 9, 2010
Sponsor:
Information provided by:
Canadian Cancer Trials Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : June 2008
Publications of Results:
White DJ, Bahlis NJ, Marcellus DC, et al.: Phase II testing of lenalidomide plus melphalan for previously untreated older patients with multiple myeloma: the NCIC CTG MY.11 trial. [Abstract] Blood 112 (11): A-2767, 2008.
White DJ, Kovacs MJ, Belch A, et al.: Phase II testing of lenalidomide plus melphalan for previously untreated older patients with multiple myeloma: toxicity data from the NCIC CTG MY.11 trial. [Abstract] Blood 110 (11): A-189, 2007.

Other Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):